Eptinezumab

6 trials 3 recruiting NNeurology/Psychiatry

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

3 Completed trials

3 Sponsors

11 Countries

Phase III

Phase II

Phase IV

Phase III: 3 Phase II: 1 Phase IV: 2

Indications tested

Migraine 4 Medication overuse headache 1

Sponsors using this IMP

H. Lundbeck A/S 4 Aarhus University Hospital 1 Ospedale San Raffaele S.r.l. 1

All trials

6 total

Exploring Eptinezumab: Unveiling Peripheral and Central Mechanisms of Action and Searching for Biomarkers of Patient Response (EUPHORIA Stud… Recruiting

2024-519337-35-00 Phase IV 1 country Ospedale San Raffaele S.r.l.
A study with eptinezumab in children and adolescents (6 to 17 years) with chronic or episodic migraine (REJOIN) Recruiting

2022-502917-27-00 Phase III 4 countries H. Lundbeck A/S
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine (PROSPECT-2) Recruiting

2024-510656-13-00 Phase III 4 countries H. Lundbeck A/S
CAT-Trial: CGRP monoclonal Antibody for Treatment of painful diabetic neuropathy: a double-blind, multicenter, placebo-controlled, internati… Ended

2022-500338-27-00 Phase II 1 country Aarhus University Hospital
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache Ended

2024-510729-24-00 Phase IV 8 countries H. Lundbeck A/S
Eptinezumab as Preventive Treatment of Migraine in Adults with Migraine Ended

2023-510183-12-00 Phase III 3 countries H. Lundbeck A/S

Showing 1–6 of 6 trials

← All drugs A–Z